ATE301120T1 - Herstellung von (1s-(1a,2b,3b,4(s*)))-4-(7-((1-(3-chlor-2-thien l)methyl)propyl)amino)-3h-imidazo(4,5-b)pyridin 3-yl)-n-ethyl-2,3- dihydroxycyclopentancarboxamid - Google Patents
Herstellung von (1s-(1a,2b,3b,4(s*)))-4-(7-((1-(3-chlor-2-thien l)methyl)propyl)amino)-3h-imidazo(4,5-b)pyridin 3-yl)-n-ethyl-2,3- dihydroxycyclopentancarboxamidInfo
- Publication number
- ATE301120T1 ATE301120T1 AT97950663T AT97950663T ATE301120T1 AT E301120 T1 ATE301120 T1 AT E301120T1 AT 97950663 T AT97950663 T AT 97950663T AT 97950663 T AT97950663 T AT 97950663T AT E301120 T1 ATE301120 T1 AT E301120T1
- Authority
- AT
- Austria
- Prior art keywords
- dihydroxycyclopentancarboxamide
- thien
- imidazo
- pyridine
- chloro
- Prior art date
Links
- OCBFFGCSTGGPSQ-UHFFFAOYSA-N [CH2]CC Chemical compound [CH2]CC OCBFFGCSTGGPSQ-UHFFFAOYSA-N 0.000 title 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical class [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/69—Two or more oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3276496P | 1996-12-11 | 1996-12-11 | |
| PCT/US1997/021439 WO1998025921A1 (en) | 1996-12-11 | 1997-11-24 | PREPARATION OF [1S-[1a,2b,3b,4a(S*)]]-4-[7-[[1-(3-CHLORO-2-THIENYL) METHYL]PROPYL]AMINO]-3H-IMIDAZO[4,5-b]PYRIDIN-3-yl]-N-ETHYL-2,3-DIHYDROXYCYCLOPENTANECARBOXAMIDE |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE301120T1 true ATE301120T1 (de) | 2005-08-15 |
Family
ID=21866680
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97950663T ATE301120T1 (de) | 1996-12-11 | 1997-11-24 | Herstellung von (1s-(1a,2b,3b,4(s*)))-4-(7-((1-(3-chlor-2-thien l)methyl)propyl)amino)-3h-imidazo(4,5-b)pyridin 3-yl)-n-ethyl-2,3- dihydroxycyclopentancarboxamid |
Country Status (26)
| Country | Link |
|---|---|
| US (2) | US6143894A (de) |
| EP (2) | EP0946550B1 (de) |
| JP (1) | JP2001506626A (de) |
| KR (4) | KR100510389B1 (de) |
| CN (3) | CN1191251C (de) |
| AP (1) | AP1063A (de) |
| AT (1) | ATE301120T1 (de) |
| AU (1) | AU738581B2 (de) |
| BG (1) | BG63805B1 (de) |
| BR (1) | BR9713705A (de) |
| CA (1) | CA2274630C (de) |
| DE (1) | DE69733897T2 (de) |
| DK (1) | DK0946550T3 (de) |
| EA (1) | EA001989B1 (de) |
| ES (1) | ES2242984T3 (de) |
| HU (1) | HUP0000342A3 (de) |
| IL (1) | IL130397A (de) |
| MX (1) | MXPA03006730A (de) |
| NO (2) | NO319722B1 (de) |
| OA (1) | OA11061A (de) |
| PT (1) | PT946550E (de) |
| SI (1) | SI0946550T1 (de) |
| SK (1) | SK71199A3 (de) |
| UA (1) | UA54479C2 (de) |
| WO (1) | WO1998025921A1 (de) |
| ZA (1) | ZA9711035B (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1140933E (pt) | 1998-12-31 | 2004-12-31 | Aventis Pharma Inc | Processo para preparar derivados n6-substituidos de desaza-adenosina |
| US7291603B2 (en) * | 2002-07-24 | 2007-11-06 | Ptc Therapeutics, Inc. | Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations |
| FR2846656B1 (fr) * | 2002-11-05 | 2004-12-24 | Servier Lab | Nouveaux derives d'imidazopyridine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU654507B2 (en) * | 1990-09-25 | 1994-11-10 | Rhone-Poulenc Rorer International (Holdings) Inc. | Compounds having antihypertensive and anti-ischemic properties |
| PL337888A1 (en) * | 1997-07-03 | 2000-09-11 | Du Pont Pharm Co | Imidazoprimidines and imidazopyridines for use in treating neurological disorders |
| KR20010087425A (ko) * | 1998-12-21 | 2001-09-15 | 오흘러 로스 제이. | N6-치환된 데아자-아데노신 유도체의 제조방법 |
-
1997
- 1997-11-24 ES ES97950663T patent/ES2242984T3/es not_active Expired - Lifetime
- 1997-11-24 DE DE69733897T patent/DE69733897T2/de not_active Expired - Fee Related
- 1997-11-24 EA EA199900527A patent/EA001989B1/ru not_active IP Right Cessation
- 1997-11-24 EP EP97950663A patent/EP0946550B1/de not_active Expired - Lifetime
- 1997-11-24 EP EP05075298A patent/EP1609791A1/de not_active Withdrawn
- 1997-11-24 UA UA99073906A patent/UA54479C2/uk unknown
- 1997-11-24 HU HU0000342A patent/HUP0000342A3/hu unknown
- 1997-11-24 JP JP52670598A patent/JP2001506626A/ja not_active Ceased
- 1997-11-24 IL IL13039797A patent/IL130397A/xx not_active IP Right Cessation
- 1997-11-24 CN CNB011370718A patent/CN1191251C/zh not_active Expired - Fee Related
- 1997-11-24 KR KR10-1999-7005191A patent/KR100510389B1/ko not_active Expired - Fee Related
- 1997-11-24 KR KR1020057023521A patent/KR20060002029A/ko not_active Ceased
- 1997-11-24 BR BR9713705-7A patent/BR9713705A/pt not_active Application Discontinuation
- 1997-11-24 SI SI9730709T patent/SI0946550T1/xx unknown
- 1997-11-24 AU AU53607/98A patent/AU738581B2/en not_active Ceased
- 1997-11-24 SK SK711-99A patent/SK71199A3/sk unknown
- 1997-11-24 PT PT97950663T patent/PT946550E/pt unknown
- 1997-11-24 CN CN2005100037721A patent/CN1660842A/zh active Pending
- 1997-11-24 KR KR1020057004675A patent/KR100571690B1/ko not_active Expired - Fee Related
- 1997-11-24 MX MXPA03006730A patent/MXPA03006730A/es not_active Application Discontinuation
- 1997-11-24 KR KR1020057023522A patent/KR20060002030A/ko not_active Withdrawn
- 1997-11-24 CN CN97180580A patent/CN1090630C/zh not_active Expired - Fee Related
- 1997-11-24 CA CA002274630A patent/CA2274630C/en not_active Expired - Fee Related
- 1997-11-24 AT AT97950663T patent/ATE301120T1/de not_active IP Right Cessation
- 1997-11-24 DK DK97950663T patent/DK0946550T3/da active
- 1997-11-24 WO PCT/US1997/021439 patent/WO1998025921A1/en not_active Ceased
- 1997-11-24 AP APAP/P/1999/001550A patent/AP1063A/en active
- 1997-12-09 ZA ZA9711035A patent/ZA9711035B/xx unknown
-
1999
- 1999-01-19 US US09/233,591 patent/US6143894A/en not_active Expired - Fee Related
- 1999-06-09 NO NO19992795A patent/NO319722B1/no unknown
- 1999-06-11 BG BG103484A patent/BG63805B1/bg unknown
- 1999-06-11 OA OA9900123A patent/OA11061A/en unknown
-
2000
- 2000-07-28 US US09/627,657 patent/US6235909B1/en not_active Expired - Fee Related
-
2005
- 2005-05-12 NO NO20052327A patent/NO20052327D0/no unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20020832D0 (no) | Imidazo(1,2-A)pyridin og pyrazolo(2,3-A)pyridin derivater | |
| DE68911033D1 (de) | Alkoxy-1,2,4-triazolo (1,5-c) pyrimidine-2-sulfonamide, Verfahren zu ihrer Herstellung und Zwischenprodukte. | |
| IS4570A (is) | Imidazó[1,2-a]pýridín afleiður | |
| TR199800085A3 (tr) | 8-Sübstitüye edilmis-1,3,8-triaza- spiro(4,5)dekan-4-on türevleri. | |
| DK0931081T3 (da) | Pyridazino-[4,5-B]-quinolin-5-oxid-derivater, deres fremstilling og deres anvendelse som glycinantagonister | |
| BE888073A (fr) | DERIVES D'IMIDAZO 4,5-b PYRIDINE LEUR PREPARATION ET LEUR UTILISATION COMME AGENTS CARDIOTONIQUES. | |
| HUP9601240A1 (en) | Pyridin and pyrimidin derivatives, suitable as beta-adrenerg agonists, pharmaceutical compositions containing the same and their intermediates | |
| FI961564L (fi) | Imidatso(1,2-a)pyridiinien alkoksialkyylikarbamaatit | |
| AU7849387A (en) | 2- or-3- aryl substituted imidazo(1,2-a)pyridines | |
| ATE218567T1 (de) | 1h-pyrido(3,4-b)indolcarboxamidderivate, ihre herstellung und therapeutische verwendung | |
| NO874302D0 (no) | Fremgangsmaate for fremstilling av 4,5-dihydro- og 4,5,6,7-tetrahydro- pyrazolo (1,5-a)pyrimidiner. | |
| DE68919731D1 (de) | Pyrimidin-Derivate, Verfahren zu deren Herstellung und diese enthaltende herbizide Zusammensetzungen. | |
| ATE301120T1 (de) | Herstellung von (1s-(1a,2b,3b,4(s*)))-4-(7-((1-(3-chlor-2-thien l)methyl)propyl)amino)-3h-imidazo(4,5-b)pyridin 3-yl)-n-ethyl-2,3- dihydroxycyclopentancarboxamid | |
| FI943294L (fi) | Alkaloidit Mappia foetidasta, niiden käyttö, ja niitä sisältävät formulloinnit | |
| DE69320668D1 (de) | Verfahren zur Herstellung von Imidazo(4,5-b)Pyridinderivaten | |
| DE59006542D1 (de) | 2,3-substituierte 1,8-Naphthyridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Antidots. | |
| DK33684D0 (da) | Pyrazino (2',3'-3,4)pyrido(1,2-a)-indol-derivater | |
| TR28699A (tr) | Imidazopiridin türevlerinin hazirlanmasi icin yöntem. | |
| DE68913338D1 (de) | 5-Fluormethyl-1,2,4-triazolo(1,5-a)pyrimidin-2-sulfonamide, Verfahren zu ihrer Herstellung und Zubereitungen als Herbizide. | |
| ZA873507B (en) | Pyrazolo(3,4-b)pyridine derivatives,processes and intermediate stages for their preparation and their use as herbicides | |
| EE9400439A (et) | Naftüridiini derivaadid, nende valmistamise meetodid, neid sisaldavad ravimvormid, eriti kasutamiseks antiproliferatiivsete preparaatidena | |
| EE200000029A (et) | 5-asendatud-3-oksadiasolüül-1,6-naftüridiin-2(1H)-ooni derivaadid | |
| DE3776199D1 (de) | 2,3-dihydro-1-(8-methyl-1,2,4-triazolo(4,3-b)pyridazin-6-yl)-4(1h)-pyridinon. | |
| FI943706A7 (fi) | Menetelmä kiraalisen etyyli-(5-amino-1,2-dihydro-2-metyyli-3-fenyylipyrido(3,4-b)pyratsin-7-yyli)karbamaatin valmistamiseksi | |
| ATE102202T1 (de) | 5-fluormethyl-1,2,4-triazolo(1,5-a)pyrimidin-2sulfonamide, verfahren zu ihrer herstellung und zubereitungen als herbizide. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0946550 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |